$CRCW
Crypto Co Stock $crcw

$crcw Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223012450 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$106.6K	$103.8K	$619.5K
YoY Change	-29.8%	-51.55%	42.57%
Cost Of Revenue	$117.3K	$103.0K	$369.3K
YoY Change	42.31%	-62.37%	34.88%
Gross Profit	-$10.71K	$750.00	$250.2K
YoY Change	-115.42%	-101.26%	55.66%
Gross Profit Margin	-10.04%	0.72%	40.39%
Selling, General & Admin	$440.4K	$588.6K	$1.896M
YoY Change	-68.66%	-15.68%	-14.09%
% of Gross Profit		78482.67%	757.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$21.74K	$87.22K
YoY Change	-100.0%	117.18%	168.38%
% of Gross Profit		2898.67%	34.86%
Operating Expenses	$451.3K	$610.4K	$1.896M
YoY Change	-68.86%	-13.8%	-15.34%
Operating Profit	-$462.0K	-$609.6K	-$3.849M
YoY Change	-66.51%	-20.59%	85.13%
Interest Expense	$346.4K	-$85.57K	$1.757M
YoY Change	-42.3%	1932.54%	-10833.4%
% of Operating Profit
Other Income/Expense, Net	$25.78K	-$142.7K	-$56.86K
YoY Change	-61.39%	-165.32%	-104.34%
Pretax Income	-$782.6K	-$837.9K	-$5.663M
YoY Change	-59.09%	51.41%	620.81%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$782.6K	-$837.9K	-$5.663M
YoY Change	-59.09%	51.41%	620.81%
Net Earnings / Revenue	-734.06%	-807.46%	-914.05%
Basic Earnings Per Share	-$0.08		-$0.24
Diluted Earnings Per Share	-$0.08	-$0.04	-$0.24
COMMON SHARES
Basic Shares Outstanding	25.62M shares	24.55M shares	23.19M shares
Diluted Shares Outstanding	35.73M shares		23.19M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.68K	$110.6K	$110.6K
YoY Change	-7.96%	46.12%	46.12%
Cash & Equivalents	$17.68K	$110.6K	$110.6K
Short-Term Investments
Other Short-Term Assets	$19.12K	$81.32K	$81.32K
YoY Change	1.54%	-5.64%	-5.64%
Inventory
Prepaid Expenses	$19.12K	$81.32K
Receivables
Other Receivables
Total Short-Term Assets	$36.80K	$191.9K	$191.9K
YoY Change	-3.27%	18.56%	18.56%
LONG-TERM ASSETS
Property, Plant & Equipment		$50.00K
YoY Change
Goodwill	$740.5K	$740.5K
YoY Change	0.0%	0.0%
Intangibles		$574.2K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$50.00K	$50.00K
YoY Change	-100.0%
Total Long-Term Assets	$1.293M	$1.365M	$1.365M
YoY Change	-44.42%	0.49%	0.49%
TOTAL ASSETS
Total Short-Term Assets	$36.80K	$191.9K	$191.9K
Total Long-Term Assets	$1.293M	$1.365M	$1.365M
Total Assets	$1.330M	$1.557M	$1.557M
YoY Change	-43.75%	2.42%	2.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.590M	$2.266M	$2.266M
YoY Change	29.06%	17.16%	17.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.408M	$2.211M	$2.211M
YoY Change	4.2%	397.49%	397.49%
Total Short-Term Liabilities	$4.998M	$4.477M	$4.477M
YoY Change	15.19%	88.24%	88.24%
LONG-TERM LIABILITIES
Long-Term Debt	$138.7K	$139.1K	$139.1K
YoY Change	-0.29%	-11.61%	-11.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$138.7K	$139.1K	$139.1K
YoY Change	-0.29%	-11.61%	-11.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.998M	$4.477M	$4.477M
Total Long-Term Liabilities	$138.7K	$139.1K	$139.1K
Total Liabilities	$5.136M	$4.616M	$4.616M
YoY Change	14.71%	82.04%	82.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.10M	-$39.53M
YoY Change	12.63%	16.72%
Common Stock	$39.29M	$36.47M
YoY Change	8.69%	11.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.807M	-$3.059M	-$3.059M
YoY Change
Total Liabilities & Shareholders Equity	$1.330M	$1.557M	$1.557M
YoY Change	-43.75%	2.42%	2.42%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$782.6K	-$837.9K	-$5.663M
YoY Change	-59.09%	51.41%	620.81%
Depreciation, Depletion And Amortization	$0.00	$21.74K	$87.22K
YoY Change	-100.0%	117.18%	168.38%
Cash From Operating Activities	-$303.1K	-$854.7K	-$1.930M
YoY Change	-22.82%	32.11%	1167.94%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$983.5K	$50.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$0.00	$983.5K	-$50.00K
YoY Change		74.59%	-93.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$26.24K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	304.1K	-104.2K	$2.015M
YoY Change	-2.88%	1795.09%	104.02%
NET CHANGE
Cash From Operating Activities	-303.1K	-854.7K	-$1.930M
Cash From Investing Activities	0.000	983.5K	-$50.00K
Cash From Financing Activities	304.1K	-104.2K	$2.015M
Net Change In Cash	1.010K	24.55K	$34.91K
YoY Change	-101.27%	-127.53%	-29.31%
FREE CASH FLOW
Cash From Operating Activities	-$303.1K	-$854.7K	-$1.930M
Capital Expenditures	$0.00	-$983.5K	$50.00K
Free Cash Flow	-$303.1K	$128.8K	-$1.980M
YoY Change	-22.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001688126
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	CRCW	Fixed Assets FixedAssets		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Depreciation Depreciation		usd
CY2021	CRCW	Loss On Disposal Of Business LossOnDisposalOfBusiness		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2022	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55726
CY2022	dei	Entity Registrant Name EntityRegistrantName	THE CRYPTO COMPANY
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4212105
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	23823 Malibu Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	#50477
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Malibu
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90265
CY2022	dei	City Area Code CityAreaCode	(424)
CY2022	dei	Local Phone Number LocalPhoneNumber	228-9955
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	6592297	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25615537	shares
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110606	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75699	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	81317	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	86179	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	191923	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	161878	usd
CY2022Q4	CRCW	Fixed Assets FixedAssets	50000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2021Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	574169	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	617501	usd
CY2022Q4	us-gaap	Assets Assets	1556561	usd
CY2021Q4	us-gaap	Assets Assets	1519848	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2265548	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1933800	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2211353	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	444500	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4476901	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2378300	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	14100	usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	32365	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4616001	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2535665	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23950380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23950380	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22205248	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22205248	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	23950	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22205	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36448046	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32830496	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39531436	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33868518	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1556561	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1519848	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	619538	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	434552	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	369313	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	273796	usd
CY2022	us-gaap	Gross Profit GrossProfit	250225	usd
CY2021	us-gaap	Gross Profit GrossProfit	160756	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1864543	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1471226	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43332	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
CY2022	us-gaap	Depreciation Depreciation	87222	usd
CY2022	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	275351	usd
CY2021	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	114020	usd
CY2022	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	1828775	usd
CY2021	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	622124	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	4099223	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2239869	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3848998	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2079113	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18265	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	145188	usd
CY2022	CRCW	Loss On Disposal Of Business LossOnDisposalOfBusiness	142728	usd
CY2022	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment	67600	usd
CY2021	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment	1164662	usd
CY2022	us-gaap	Interest Expense InterestExpense	1757057	usd
CY2021	us-gaap	Interest Expense InterestExpense	16367	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5662918	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-785630	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5662918	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-785630	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.24
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23188092	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22062375	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395647	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	20929	usd
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.00
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	825000	usd
CY2021	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	715215	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	604317	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-785630	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.28
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
CY2022	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	2060377	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	43750	usd
CY2022	CRCW	Adjustments To Additional Paid In Capital Debt Discount For Warrants AdjustmentsToAdditionalPaidInCapitalDebtDiscountForWarrants	1488928	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5662918	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5662918	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-785630	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	130554	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32499	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2104126	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	736144	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1488928	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	327608	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	53493	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3900	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4862	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	86179	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	331748	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	518	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1930308	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-152241	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	786151	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	50000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-786151	usd
CY2021	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	18265	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	761671	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2750646	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	144500	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26240	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	825000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2015215	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	987765	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34907	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49373	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26326	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	110606	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	604317	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z7gXOYOWjal3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zVZI92d3oCq3">Reclassifications </span>– </b>Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. Such reclassifications had no effect on the Company’s financial position, results of operations or cashflows.</span></p>
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1349457	usd
CY2022Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	650000	usd
CY2022Q4	us-gaap	Cash Cash	86061	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5662918	usd
CY2022	CRCW	Working Capital WorkingCapital	4284978	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39531436	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zZttr4xYruA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zefKzcigXc2d">Use of estimates </span></b>– The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the recoverability and useful lives of long-lived assets, allocation of revenue on software subscriptions, valuation of goodwill from business acquisitions, valuation and recoverability of investments, valuation allowances of deferred taxes, and share- based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	54166	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43332	usd
CY2022Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q4	CRCW	Investment In Cryptocurrency InvestmentInCryptocurrency	0	usd
CY2021Q4	CRCW	Investment In Cryptocurrency InvestmentInCryptocurrency	0	usd
CY2022Q4	CRCW	Investment In Noncryptocurrency InvestmentInNoncryptocurrency	0	usd
CY2022	CRCW	Other Income Recovery Of Token Investment OtherIncomeRecoveryOfTokenInvestment	67600	usd
CY2022	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	three to five years
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	574169	usd
CY2021Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	617501	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281349	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281349	shares
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	10613000	usd
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	expire in 2037
CY2022	us-gaap	Marketing Expense MarketingExpense	31777	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	33965	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281349	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
CY2022	CRCW	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P3Y3M
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0040	pure
CY2022Q4	CRCW	Compensation Expense Related To Restricted Stock Options CompensationExpenseRelatedToRestrictedStockOptions	2086151	usd
CY2021Q4	CRCW	Compensation Expense Related To Restricted Stock Options CompensationExpenseRelatedToRestrictedStockOptions	715215	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2086151	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	748146	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.50
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2009167	shares
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	1.50	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	1.50	pure

Files In Submission

Name	View Source	Status
0001493152-23-012450-index-headers.html	Edgar Link	pending
0001493152-23-012450-index.html	Edgar Link	pending
0001493152-23-012450.txt	Edgar Link	pending
0001493152-23-012450-xbrl.zip	Edgar Link	pending
crcw-20221231.xsd	Edgar Link	pending
ex10-21.htm	Edgar Link	pending
ex10-21_001.jpg	Edgar Link	pending
ex10-21_002.jpg	Edgar Link	pending
ex10-21_003.jpg	Edgar Link	pending
ex10-21_004.jpg	Edgar Link	pending
ex10-21_005.jpg	Edgar Link	pending
ex10-21_006.jpg	Edgar Link	pending
ex10-21_007.jpg	Edgar Link	pending
ex10-21_008.jpg	Edgar Link	pending
ex10-21_009.jpg	Edgar Link	pending
ex10-21_010.jpg	Edgar Link	pending
ex10-21_011.jpg	Edgar Link	pending
ex10-21_012.jpg	Edgar Link	pending
ex10-21_013.jpg	Edgar Link	pending
ex10-21_014.jpg	Edgar Link	pending
ex10-21_015.jpg	Edgar Link	pending
ex10-21_016.jpg	Edgar Link	pending
ex10-21_017.jpg	Edgar Link	pending
ex10-21_018.jpg	Edgar Link	pending
ex10-21_019.jpg	Edgar Link	pending
ex10-22.htm	Edgar Link	pending
ex10-22_001.jpg	Edgar Link	pending
ex10-22_002.jpg	Edgar Link	pending
ex10-22_003.jpg	Edgar Link	pending
ex10-22_004.jpg	Edgar Link	pending
ex10-22_005.jpg	Edgar Link	pending
ex10-22_006.jpg	Edgar Link	pending
ex10-22_007.jpg	Edgar Link	pending
ex10-22_008.jpg	Edgar Link	pending
ex10-22_009.jpg	Edgar Link	pending
ex10-22_010.jpg	Edgar Link	pending
ex10-22_011.jpg	Edgar Link	pending
ex10-22_012.jpg	Edgar Link	pending
ex10-22_013.jpg	Edgar Link	pending
ex10-22_014.jpg	Edgar Link	pending
ex10-22_015.jpg	Edgar Link	pending
ex10-22_016.jpg	Edgar Link	pending
ex10-22_017.jpg	Edgar Link	pending
ex10-22_018.jpg	Edgar Link	pending
ex10-22_019.jpg	Edgar Link	pending
ex10-22_020.jpg	Edgar Link	pending
ex10-22_021.jpg	Edgar Link	pending
ex10-22_022.jpg	Edgar Link	pending
ex10-22_023.jpg	Edgar Link	pending
ex10-22_024.jpg	Edgar Link	pending
ex10-23.htm	Edgar Link	pending
ex10-23_001.jpg	Edgar Link	pending
crcw-20221231_lab.xml	Edgar Link	unprocessable
ex10-23_002.jpg	Edgar Link	pending
ex10-23_003.jpg	Edgar Link	pending
ex10-23_004.jpg	Edgar Link	pending
ex10-23_005.jpg	Edgar Link	pending
ex10-23_006.jpg	Edgar Link	pending
ex10-23_007.jpg	Edgar Link	pending
ex10-23_008.jpg	Edgar Link	pending
ex10-23_009.jpg	Edgar Link	pending
ex10-23_010.jpg	Edgar Link	pending
ex10-23_011.jpg	Edgar Link	pending
ex10-23_012.jpg	Edgar Link	pending
ex10-23_013.jpg	Edgar Link	pending
ex10-23_014.jpg	Edgar Link	pending
ex10-23_015.jpg	Edgar Link	pending
ex10-23_016.jpg	Edgar Link	pending
ex10-23_017.jpg	Edgar Link	pending
ex10-23_018.jpg	Edgar Link	pending
ex10-23_019.jpg	Edgar Link	pending
ex10-24.htm	Edgar Link	pending
ex10-24_001.jpg	Edgar Link	pending
ex10-24_002.jpg	Edgar Link	pending
ex10-24_003.jpg	Edgar Link	pending
ex10-24_004.jpg	Edgar Link	pending
ex10-24_005.jpg	Edgar Link	pending
ex10-24_006.jpg	Edgar Link	pending
ex10-24_007.jpg	Edgar Link	pending
ex10-24_008.jpg	Edgar Link	pending
ex10-24_009.jpg	Edgar Link	pending
ex10-24_010.jpg	Edgar Link	pending
ex10-24_011.jpg	Edgar Link	pending
ex10-24_012.jpg	Edgar Link	pending
ex10-24_013.jpg	Edgar Link	pending
ex10-24_014.jpg	Edgar Link	pending
ex10-24_015.jpg	Edgar Link	pending
ex10-24_016.jpg	Edgar Link	pending
ex10-24_017.jpg	Edgar Link	pending
ex10-24_018.jpg	Edgar Link	pending
ex10-24_019.jpg	Edgar Link	pending
ex10-24_020.jpg	Edgar Link	pending
ex10-24_021.jpg	Edgar Link	pending
ex10-24_022.jpg	Edgar Link	pending
ex10-24_023.jpg	Edgar Link	pending
ex10-24_024.jpg	Edgar Link	pending
ex10-24_025.jpg	Edgar Link	pending
ex10-24_026.jpg	Edgar Link	pending
ex10-24_027.jpg	Edgar Link	pending
ex10-25.htm	Edgar Link	pending
ex10-25_001.jpg	Edgar Link	pending
ex10-25_002.jpg	Edgar Link	pending
ex10-25_003.jpg	Edgar Link	pending
ex10-25_004.jpg	Edgar Link	pending
ex10-25_005.jpg	Edgar Link	pending
ex10-25_006.jpg	Edgar Link	pending
ex10-25_007.jpg	Edgar Link	pending
ex10-25_008.jpg	Edgar Link	pending
ex10-25_009.jpg	Edgar Link	pending
ex10-25_010.jpg	Edgar Link	pending
ex10-25_011.jpg	Edgar Link	pending
ex10-25_012.jpg	Edgar Link	pending
ex10-25_013.jpg	Edgar Link	pending
ex10-25_014.jpg	Edgar Link	pending
ex10-25_015.jpg	Edgar Link	pending
ex10-25_016.jpg	Edgar Link	pending
ex10-25_017.jpg	Edgar Link	pending
ex10-25_018.jpg	Edgar Link	pending
ex10-25_019.jpg	Edgar Link	pending
ex10-25_020.jpg	Edgar Link	pending
ex10-25_021.jpg	Edgar Link	pending
ex10-25_022.jpg	Edgar Link	pending
ex10-25_023.jpg	Edgar Link	pending
ex10-25_024.jpg	Edgar Link	pending
ex10-26.htm	Edgar Link	pending
ex10-26_001.jpg	Edgar Link	pending
ex10-26_002.jpg	Edgar Link	pending
ex10-26_003.jpg	Edgar Link	pending
ex10-26_004.jpg	Edgar Link	pending
ex10-26_005.jpg	Edgar Link	pending
ex10-26_006.jpg	Edgar Link	pending
ex10-26_007.jpg	Edgar Link	pending
ex10-26_008.jpg	Edgar Link	pending
ex10-26_009.jpg	Edgar Link	pending
ex10-26_010.jpg	Edgar Link	pending
ex10-26_011.jpg	Edgar Link	pending
ex10-26_012.jpg	Edgar Link	pending
ex10-26_013.jpg	Edgar Link	pending
ex10-26_014.jpg	Edgar Link	pending
ex10-26_015.jpg	Edgar Link	pending
ex10-26_016.jpg	Edgar Link	pending
ex10-26_017.jpg	Edgar Link	pending
ex10-26_018.jpg	Edgar Link	pending
ex10-26_019.jpg	Edgar Link	pending
ex10-26_020.jpg	Edgar Link	pending
ex10-26_021.jpg	Edgar Link	pending
ex10-26_022.jpg	Edgar Link	pending
ex10-26_023.jpg	Edgar Link	pending
ex10-26_024.jpg	Edgar Link	pending
ex10-26_025.jpg	Edgar Link	pending
ex10-26_026.jpg	Edgar Link	pending
ex10-26_027.jpg	Edgar Link	pending
ex10-26_028.jpg	Edgar Link	pending
ex10-27.htm	Edgar Link	pending
ex10-27_001.jpg	Edgar Link	pending
ex10-27_002.jpg	Edgar Link	pending
ex10-27_003.jpg	Edgar Link	pending
ex10-27_004.jpg	Edgar Link	pending
ex10-27_005.jpg	Edgar Link	pending
ex10-27_006.jpg	Edgar Link	pending
ex10-27_007.jpg	Edgar Link	pending
ex10-27_008.jpg	Edgar Link	pending
ex10-27_009.jpg	Edgar Link	pending
ex10-27_010.jpg	Edgar Link	pending
ex10-27_011.jpg	Edgar Link	pending
ex10-27_012.jpg	Edgar Link	pending
ex10-27_013.jpg	Edgar Link	pending
ex10-27_014.jpg	Edgar Link	pending
ex10-27_015.jpg	Edgar Link	pending
ex10-27_016.jpg	Edgar Link	pending
ex10-27_017.jpg	Edgar Link	pending
ex10-27_018.jpg	Edgar Link	pending
ex10-27_019.jpg	Edgar Link	pending
ex10-28.htm	Edgar Link	pending
ex10-28_001.jpg	Edgar Link	pending
ex10-28_002.jpg	Edgar Link	pending
ex10-28_003.jpg	Edgar Link	pending
ex10-28_004.jpg	Edgar Link	pending
ex10-28_005.jpg	Edgar Link	pending
ex10-28_006.jpg	Edgar Link	pending
ex10-28_007.jpg	Edgar Link	pending
ex10-28_008.jpg	Edgar Link	pending
ex10-28_009.jpg	Edgar Link	pending
ex10-28_010.jpg	Edgar Link	pending
ex10-28_011.jpg	Edgar Link	pending
ex10-28_012.jpg	Edgar Link	pending
ex10-28_013.jpg	Edgar Link	pending
ex10-29.htm	Edgar Link	pending
ex10-29_001.jpg	Edgar Link	pending
ex10-29_002.jpg	Edgar Link	pending
ex10-29_003.jpg	Edgar Link	pending
ex10-29_004.jpg	Edgar Link	pending
ex10-29_005.jpg	Edgar Link	pending
ex10-29_006.jpg	Edgar Link	pending
ex10-29_007.jpg	Edgar Link	pending
ex10-29_008.jpg	Edgar Link	pending
ex10-29_009.jpg	Edgar Link	pending
ex10-29_010.jpg	Edgar Link	pending
ex10-29_011.jpg	Edgar Link	pending
ex10-30.htm	Edgar Link	pending
ex10-30_001.jpg	Edgar Link	pending
ex10-30_002.jpg	Edgar Link	pending
ex10-30_003.jpg	Edgar Link	pending
ex10-30_004.jpg	Edgar Link	pending
ex10-30_005.jpg	Edgar Link	pending
ex10-30_006.jpg	Edgar Link	pending
ex10-30_007.jpg	Edgar Link	pending
ex10-30_008.jpg	Edgar Link	pending
ex10-30_009.jpg	Edgar Link	pending
ex10-30_010.jpg	Edgar Link	pending
ex10-30_011.jpg	Edgar Link	pending
ex10-30_012.jpg	Edgar Link	pending
ex10-30_013.jpg	Edgar Link	pending
ex10-30_014.jpg	Edgar Link	pending
ex10-30_015.jpg	Edgar Link	pending
ex10-30_016.jpg	Edgar Link	pending
ex10-30_017.jpg	Edgar Link	pending
ex10-30_018.jpg	Edgar Link	pending
ex10-30_019.jpg	Edgar Link	pending
ex10-30_020.jpg	Edgar Link	pending
ex10-30_021.jpg	Edgar Link	pending
ex10-30_022.jpg	Edgar Link	pending
ex10-30_023.jpg	Edgar Link	pending
ex10-30_024.jpg	Edgar Link	pending
ex10-30_025.jpg	Edgar Link	pending
ex10-31.htm	Edgar Link	pending
ex10-31_001.jpg	Edgar Link	pending
ex10-31_002.jpg	Edgar Link	pending
ex10-31_003.jpg	Edgar Link	pending
ex10-31_004.jpg	Edgar Link	pending
ex10-31_005.jpg	Edgar Link	pending
ex10-31_006.jpg	Edgar Link	pending
ex10-31_007.jpg	Edgar Link	pending
ex10-31_008.jpg	Edgar Link	pending
ex10-31_009.jpg	Edgar Link	pending
ex10-31_010.jpg	Edgar Link	pending
ex10-31_011.jpg	Edgar Link	pending
ex10-31_012.jpg	Edgar Link	pending
ex10-31_013.jpg	Edgar Link	pending
ex10-31_014.jpg	Edgar Link	pending
ex10-31_015.jpg	Edgar Link	pending
ex10-31_016.jpg	Edgar Link	pending
ex10-31_017.jpg	Edgar Link	pending
ex10-31_018.jpg	Edgar Link	pending
ex10-31_019.jpg	Edgar Link	pending
ex10-31_020.jpg	Edgar Link	pending
ex10-31_021.jpg	Edgar Link	pending
ex10-31_022.jpg	Edgar Link	pending
ex10-31_023.jpg	Edgar Link	pending
ex10-31_024.jpg	Edgar Link	pending
ex10-31_025.jpg	Edgar Link	pending
ex10-31_026.jpg	Edgar Link	pending
ex10-31_027.jpg	Edgar Link	pending
ex10-31_028.jpg	Edgar Link	pending
ex10-32.htm	Edgar Link	pending
ex10-32_001.jpg	Edgar Link	pending
ex10-32_002.jpg	Edgar Link	pending
ex10-32_003.jpg	Edgar Link	pending
ex10-32_004.jpg	Edgar Link	pending
ex10-32_005.jpg	Edgar Link	pending
ex10-32_006.jpg	Edgar Link	pending
ex10-32_007.jpg	Edgar Link	pending
ex10-32_008.jpg	Edgar Link	pending
ex10-32_009.jpg	Edgar Link	pending
ex10-32_010.jpg	Edgar Link	pending
ex10-32_011.jpg	Edgar Link	pending
ex10-32_012.jpg	Edgar Link	pending
ex10-33.htm	Edgar Link	pending
ex10-33_001.jpg	Edgar Link	pending
ex10-33_002.jpg	Edgar Link	pending
ex10-33_003.jpg	Edgar Link	pending
ex10-33_004.jpg	Edgar Link	pending
ex10-33_005.jpg	Edgar Link	pending
ex10-33_006.jpg	Edgar Link	pending
ex10-33_007.jpg	Edgar Link	pending
ex10-33_008.jpg	Edgar Link	pending
ex10-33_009.jpg	Edgar Link	pending
ex10-33_010.jpg	Edgar Link	pending
ex10-33_011.jpg	Edgar Link	pending
ex10-33_012.jpg	Edgar Link	pending
ex10-34.htm	Edgar Link	pending
ex10-34_001.jpg	Edgar Link	pending
ex10-34_002.jpg	Edgar Link	pending
ex10-34_003.jpg	Edgar Link	pending
ex10-34_004.jpg	Edgar Link	pending
ex10-34_005.jpg	Edgar Link	pending
ex10-34_006.jpg	Edgar Link	pending
ex10-34_007.jpg	Edgar Link	pending
ex10-34_008.jpg	Edgar Link	pending
ex10-34_009.jpg	Edgar Link	pending
ex10-34_010.jpg	Edgar Link	pending
ex10-34_011.jpg	Edgar Link	pending
ex10-34_012.jpg	Edgar Link	pending
ex10-35.htm	Edgar Link	pending
ex10-35_001.jpg	Edgar Link	pending
ex10-35_002.jpg	Edgar Link	pending
ex10-35_003.jpg	Edgar Link	pending
ex10-35_004.jpg	Edgar Link	pending
ex10-35_005.jpg	Edgar Link	pending
ex10-35_006.jpg	Edgar Link	pending
ex10-35_007.jpg	Edgar Link	pending
ex10-35_008.jpg	Edgar Link	pending
ex10-35_009.jpg	Edgar Link	pending
ex10-35_010.jpg	Edgar Link	pending
ex10-35_011.jpg	Edgar Link	pending
ex10-35_012.jpg	Edgar Link	pending
ex10-36.htm	Edgar Link	pending
ex10-36_001.jpg	Edgar Link	pending
ex10-36_002.jpg	Edgar Link	pending
ex10-36_003.jpg	Edgar Link	pending
ex10-36_004.jpg	Edgar Link	pending
ex10-36_005.jpg	Edgar Link	pending
ex10-36_006.jpg	Edgar Link	pending
ex10-36_007.jpg	Edgar Link	pending
ex10-36_008.jpg	Edgar Link	pending
ex10-36_009.jpg	Edgar Link	pending
ex10-36_010.jpg	Edgar Link	pending
ex10-36_011.jpg	Edgar Link	pending
ex10-36_012.jpg	Edgar Link	pending
ex10-36_013.jpg	Edgar Link	pending
ex10-37.htm	Edgar Link	pending
ex10-37_001.jpg	Edgar Link	pending
ex10-37_002.jpg	Edgar Link	pending
ex10-37_003.jpg	Edgar Link	pending
ex10-37_004.jpg	Edgar Link	pending
ex10-37_005.jpg	Edgar Link	pending
ex10-37_006.jpg	Edgar Link	pending
ex10-37_007.jpg	Edgar Link	pending
ex10-37_008.jpg	Edgar Link	pending
ex10-37_009.jpg	Edgar Link	pending
ex10-37_010.jpg	Edgar Link	pending
ex10-37_011.jpg	Edgar Link	pending
ex10-38.htm	Edgar Link	pending
ex10-38_001.jpg	Edgar Link	pending
ex10-38_002.jpg	Edgar Link	pending
ex10-38_003.jpg	Edgar Link	pending
ex10-38_004.jpg	Edgar Link	pending
ex10-38_005.jpg	Edgar Link	pending
ex10-38_006.jpg	Edgar Link	pending
ex10-38_007.jpg	Edgar Link	pending
ex10-38_008.jpg	Edgar Link	pending
ex10-38_009.jpg	Edgar Link	pending
ex10-39.htm	Edgar Link	pending
ex10-39_001.jpg	Edgar Link	pending
ex10-39_002.jpg	Edgar Link	pending
ex10-39_003.jpg	Edgar Link	pending
ex10-39_004.jpg	Edgar Link	pending
ex10-39_005.jpg	Edgar Link	pending
ex10-39_006.jpg	Edgar Link	pending
ex10-39_007.jpg	Edgar Link	pending
ex10-39_008.jpg	Edgar Link	pending
ex10-39_009.jpg	Edgar Link	pending
ex10-39_010.jpg	Edgar Link	pending
ex10-39_011.jpg	Edgar Link	pending
ex10-39_012.jpg	Edgar Link	pending
ex10-39_013.jpg	Edgar Link	pending
ex10-39_014.jpg	Edgar Link	pending
ex10-40.htm	Edgar Link	pending
ex10-40_001.jpg	Edgar Link	pending
ex10-40_002.jpg	Edgar Link	pending
ex10-40_003.jpg	Edgar Link	pending
ex10-40_004.jpg	Edgar Link	pending
ex10-40_005.jpg	Edgar Link	pending
ex10-40_006.jpg	Edgar Link	pending
ex10-40_007.jpg	Edgar Link	pending
ex10-40_008.jpg	Edgar Link	pending
ex10-40_009.jpg	Edgar Link	pending
ex10-40_010.jpg	Edgar Link	pending
ex10-40_011.jpg	Edgar Link	pending
ex10-40_012.jpg	Edgar Link	pending
ex10-40_013.jpg	Edgar Link	pending
ex10-41.htm	Edgar Link	pending
ex10-41_001.jpg	Edgar Link	pending
ex10-41_002.jpg	Edgar Link	pending
ex10-41_003.jpg	Edgar Link	pending
ex10-41_004.jpg	Edgar Link	pending
ex10-41_005.jpg	Edgar Link	pending
ex10-41_006.jpg	Edgar Link	pending
ex10-41_007.jpg	Edgar Link	pending
ex10-41_008.jpg	Edgar Link	pending
ex10-41_009.jpg	Edgar Link	pending
ex10-41_010.jpg	Edgar Link	pending
ex10-41_011.jpg	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crcw-20221231_def.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
crcw-20221231_pre.xml	Edgar Link	unprocessable
crcw-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRCW
Crypto Co Stock $crcw

2023 Q2 Form 10-K Financial Statement

#000149315223012450 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW Crypto Co Stock $crcw

2023 Q2 Form 10-K Financial Statement

#000149315223012450 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW
Crypto Co Stock $crcw